- Home
- SAMG vs BDTX Comparison
SAMG vs BDTX Comparison
Compare SAMG & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SAMG | BDTX |
|---|---|---|
| Founded | 2002 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.0M | 116.8M |
| IPO Year | 2012 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SAMG | BDTX |
|---|---|---|
| Price | $13.25 | $2.70 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 42.0K | ★ 571.9K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 6.43% | N/A |
| EPS Growth | N/A | ★ 130.71 |
| EPS | ★ 0.56 | 0.39 |
| Revenue | ★ $91,358,000.00 | N/A |
| Revenue This Year | $8.99 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $23.32 | ★ $6.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.79 | $1.31 |
| 52 Week High | $16.97 | $4.94 |
Technical Indicators
Market Signals| Indicator | SAMG | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 46.84 | 68.00 |
| Support Level | $13.27 | $2.45 |
| Resistance Level | $16.83 | $2.86 |
| Average True Range (ATR) | 0.57 | 0.14 |
| MACD | 0.05 | 0.06 |
| Stochastic Oscillator | 41.22 | 97.90 |
Price Performance
Historical ComparisonAbout SAMG Silvercrest Asset Management Group Inc.
Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income, and cash, as well as non-traditional investment strategies including hedge funds, private equity funds, real estate, and commodities. The firm offers a full suite of complementary and customized family office services for families seeking comprehensive oversight of their financial affairs. The company derives revenues from Managed accounts, Silvercrest funds, Tax and family office services, and Fund administration. The firm generates the majority of its revenue from Managed Accounts.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.